2008 WHO classification Acute erythroid leukemia: a reassessment using criteria refined in the
暂无分享,去创建一个
H. Kantarjian | L. Medeiros | L. Abruzzo | C. Garcia | G. Tang | Z. Zuo | Armen Kasyan | R. Hasserjian | Alan Wang
[1] F. Naeim. 8 – Myelodysplastic Syndromes/Neoplasms—Overview , 2013 .
[2] H. Kantarjian,et al. Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution , 2009, Leukemia.
[3] H. Koeppen,et al. Application of COLD-PCR for improved detection of KRAS mutations in clinical samples , 2009, Modern Pathology.
[4] J. Merker,et al. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. , 2008, Blood.
[5] B. Woda,et al. Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification , 2008, Modern Pathology.
[6] A. Hagemeijer,et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] G. Ehninger,et al. MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients. , 2008, Blood.
[8] Thomas H Müller,et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. , 2007, Blood.
[9] L. Medeiros,et al. Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia. , 2006, American journal of clinical pathology.
[10] U. Germing,et al. Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals , 2006, British journal of haematology.
[11] R. Berger,et al. Cytogenetic study of 75 erythroleukemias. , 2005, Cancer genetics and cytogenetics.
[12] E. Estey,et al. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias , 2005, Leukemia.
[13] U. Germing,et al. Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals. , 2003, Leukemia research.
[14] C. Ross,et al. Diagnostic criteria for acute erythroleukemia. , 2003, Blood.
[15] M. Labopin,et al. Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT). , 2002, Blood.
[16] F. Picard,et al. Erythroleukemia: a need for a new definition , 2002, Leukemia.
[17] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[18] N. Harris,et al. Acute myeloid leukaemia not otherwise categorised. . , 2001 .
[19] K Wheatley,et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.
[20] L. Kanter‐Lewensohn,et al. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. , 1997, Leukemia research.
[21] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.
[22] O. Olopade,et al. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. , 1992, Blood.
[23] G Flandrin,et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.